Current Mandates:
Work Experience:
BaselArea, CEO
Settlement of companies and provide access to commercial properties, active in eight countries
on behalf of four cantons. Focus on:
strategy - efficiency - key account management.
Zur Rose AG, SeniorVP (Direktorin)
Group Head Corporate Services
Responsible for business development, public affairs, corporate communications and certified quality assurance. Focus on:
M&A - strategy - corporate management.
Swiss Life AG, SeniorVP (Direktorin)
Group Head Investor Relations
Focus on: corporate governance - shareholder structure & activism - transparency.
Clariant Ltd., FirstVP
Group Head Investor Relations
Focus on: crisis exit strategies -
consensus management - positioning.
Deutsche Telekom, Ass. Director
Group Deputy Head IR USA
Focus on: US authorities (SEC, NYSE) -
acquisition retail clients - IPO - capital increase.
My international experience for you.
Iris Maria Welten is Chair and Board member of several companies as well as co-founder of the consulting firm Welten & Welten AG. She is focused on Inspirational Leadership to transform life patterns for a happier and more successfull life. Further, she teaches at the University of Applied Sciences Bern Corporate Governance. Her profound experience includes international capital markets, leadership of 8 country representatives, broad experience in 6 industries and the management of 9 business units. In addition, she is well connected economically as well as politically (communal, state and federal level). She worked in Munich, Miami, Hong Kong and New York for large stock exchange listed companies in leading Group Corporate functions as well as CEO.
Education:
Positive Intelligence Certified CPQC Coach
Mental Fitness for performance & happiness
Google Search Inside Yourself Certified Program
Mindful Leadership
University of St. Gallen, Bord of Directors School
Corporate Governance Certification
IMD Lausanne
International Strategy Development
ZFU Zug
Change Management und Leadership
SGO Training AG
“Advanced” Project Management
Train GmbH
Media training and crisis communication
Ludwig-Maximilians-Universität Munich
Master degree in Science of Communication, bachelor in business administration, bachelor in market psychology (summa cum laude)
My international experience for you.
Harry Welten has more than a decade of Board of Directors experience in listed and privately held biotech companies as Chairman, Vice-Chairman and member of the Board of Directors. Further, he has extensive hands-on experience as Audit Commitee Chair as well as Chair of the Nomination and Compensation Commitee. He has more than 20 years of comprehensive U.S. and European executive management experience in Biotech/ Pharma and Banking. Harry is a past Chief Financial Officer of several SIX Swiss Exchange Main Segment listed biotech companies and was a key player in one of the largest biotech IPO’s in Europe as well as in numerous industry shaping deals such as M&A as well as spin-offs. During his tenure as CFO, Harry raised more than CHF 320 mln through Venture Capital rounds/M&A/IPO/capital markets in Europe and the U.S.. In addition, he successfully managed the transition from a private equity financed business into a SIX Swiss Exchange main segment listed company including private and public fund raising. Last but not least he was responsible for Corporate Functions such as Corporate Governance, Risk Management, Corporate Finance, Corporate Communications, IT, Legal, Human Resources, Investor Relations and Strategy.
Education:
Columbia University - Business School NY/USA
Master of Business Administration (Hons.)
Zurich School of Management
Degree in Business Administration and Economics (Betriebsökonom KSZ)
KV Business School
Federal degree in Banking
(Eidgenössisch diplomierter Bankfachmann)
KV Business School
Trade school degree in commerce
(Lehre kaufmännischer Angestellter)
Current Mandates:
Work Experience:
Kuros Biosciences AG, CFO
Listed on the main segment of the SIX Swiss Exchange. Focus on: debt restructuring - equity financing - strategic acquisitions.
Nitec Pharma AG, CFO
Merged with Horizon Pharma from the USA, now listed on Nasdaq, USA.
Focus on: M&A negotiation - implementation - execution.
Arpida AG (now Evolva Holding AG), CFO
Listed on the main segment of the SIX Swiss Exchange. Focus on: equity financing - IPO - restructuring - reverse merger.
UBS AG, Zurich and New York USA, Director
Focus on: client relationships - department integration - loan portfolio repositioning.